PINK1 and myeloid sarcoma: For example, IRF1 exacerbates inflammation in PD via VCAM-1 upregulation mediated by PINK1 mutants, whereas it aggravates demyelination injury in MS by regulating oligodendrocyte pyroptosis (caspase1-dependent) [73,86].